Title: Sherin Salaheldin Abdel-Meguid, et al. Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseases. WO2014150395A1.
946243-41-0
946365-10-2
946243-33-0
946286-58-4
1021219-79-3
1021219-53-3
5689-39-4 | 1-(1-methyl-1H-indol-3-yl)propan-2-amine hydrochloride | AA01E6ZM | MFCD31665981
1226033-55-1 | 4-chloro-n-(3-piperidinylmethyl)aniline | AA01E77E | MFCD16313464
2023240-30-2 | 1-{[(9H-fluoren-9-yl)methoxy]carbonyl}-4-(methoxymethyl)piperidine-4-carboxylic acid | AA01E79K | MFCD30730410
2126160-32-3 | 2-(pyrrolidin-1-yl)-6-(pyrrolidin-3-yl)pyrimidin-4-ol dihydrochloride | AA01E7D2 | MFCD30751535
2126161-06-4 | (3-bromo-1-methyl-1H-pyrazol-4-yl)methanamine hydrochloride | AA01E7G6 | MFCD30751426
1291445-04-9 | 4-(oxan-4-yloxy)butanoic acid | AA01E7JD | MFCD14614834
2094139-05-4 | 4-bromo-3-(2-cyclohexylethoxy)aniline hydrochloride | AA01E7MK | MFCD30751325
2095410-99-2 | 2-{[4-(trifluoromethyl)phenyl]methoxy}pyridine-3-carboxylic acid | AA01E7P7 | MFCD30730488
1271478-86-4 | 4-{[2-(4-methyl-1,3-thiazol-2-yl)ethyl]amino}benzoic acid | AA01E7U6 | MFCD19123214
1820580-05-9 | 3-(propan-2-yl)-2,3-dihydro-1H-inden-1-ol, trans | AA01E7X7 | MFCD28390117